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Chapter 2 ? Are the outcomes of clinical pathways
evidence-based?




To evaluate the validity of study outcomes of published papers that report the
effects of clinical pathways (CPs).
Method
Systematic review based on two search strategies, including searching Medline,
CINAHL, Embase, Psychinfo and Picarta from 1995 till 2005 and ISI Web of
KnowledgeSM. We included randomized controlled or quasi-experimental
studies evaluating the efficacy of clinical pathway application. Assessment of the
methodological quality of the studies included randomization, power analysis,
selection bias, validity of outcome indicators, appropriateness of statistical tests,
direct (matching) and indirect (statistical) control for confounders. Outcomes
included  length  of  stay,  costs,  readmission  rate  and  complications.  Two
reviewers independently assessed the methodological quality of the selected
papers and recorded the findings with an evaluation tool developed from a set of
items for quality assessment derived from the Cochrane Library and other
publications.
Results
The study sample comprised of 115 publications. A total of 91.3% of the studies
comprised of retrospective studies and 8.7% were randomized controlled studies.
Using a quality-scoring assessment tool, 33% of the papers were classified as of
good  quality,  whereas  67%  were  classified  as  of  low  quality.  Of  the  studies,
10.4% controlled for confounding by matching and 59.1% adopted parametric
statistical tests without testing variables on normal distribution. Differences in
outcomes were not always statistically tested.
Conclusion
Readers should be cautious when interpreting the results of clinical pathway
evaluation studies because of the confounding factors and sources of
contamination affecting the evidence-based validity of the outcomes.
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2.1 Introduction
Clinical pathways have been developed in health care as multidisciplinary care
plans that outline the sequence and timing of actions necessary for achieving
expected patient outcomes and organizational goals regarding quality, costs,
patient satisfaction and efficiency. The concept of clinical pathways (CPs) refers
to specific guidelines for care that describe patient treatment goals and define a
sequence and timing of intervention for meeting those goals efficiently1. They
can also be defined as care plans that detail essential steps in patient care with
a view to describing the expected progress of the patient2. They are also known
as critical pathways, integrated care pathway, critical path, care maps™ and
care paths and they are being embraced in many systems.
In an attempt to evaluate the efficacy of integrated care pathways, Campbell et
al. posed the question ‘Are clinical pathways effective in improving patient
care?’3. They used the results of a comprehensive review performed by the
National Health Service in Wales in 1996, which was comprised of
approximately 4000 references to integrated care pathways and related topics
worldwide. The studies that were found mainly described benefits that were
experienced and addressed concerns associated with the use of pathways or
practical barriers to implementation. Most of the studies they found were
uncontrolled ‘before–after’ studies and no randomized controlled studies were
found. The authors came to the conclusion that ‘these reports do not provide
reliable evidence and publication bias is highly likely, favoring publications
reporting favorable experience’.
Every et al. reported that in cardiovascular medicine, although the studies they
evaluated were somewhat under-powered, the overall experience had been
promising1.  CPs  applied  to  patients  with  a  cardiovascular  disease  showed  a
tendency towards a decreased treatment variation, improved guideline
compliance and reduced costs. However, the evidence of the effectiveness of CPs
in cardiovascular medicine cannot be generalized because of the insufficient
number of controlled studies. Renholm et al. concluded in a review article that
clinical pathways had positive effects on patient-care outcome, although some
studies  did  suggest  that  the  use  of  CPs  had  no  influence  on  patient-care
outcomes, while by the same token they also stated that there was no evidence
at all that they had any negative effect2.
Similarly, Van Herck et al. concluded  that  CPs  did  have  a  positive  effect  on
patient outcome, but they did not take methodological weaknesses into
consideration, because they analysed most of the manuscripts (55.5%) by means
of abstracts4. Additionally, they expressed their concerns about ‘publication bias




Kim et al. conducted a systematic review which focused on the effectiveness of
CPs  for  total  knee  and  total  hip  arthroplasty5.  They  included  11  papers  and
identified only one randomized controlled study. They reported a decrease in
length  of  stay  (LOS)  and  in  costs  with  either  reduced  or  unchanged  rates  of
complications and either improvement or no change in patient-reported
outcomes. Furthermore, they concluded that, although the data in their review
supported the effectiveness of CPs, ‘definitive conclusions cannot be made
because of methodological limitations’.
Another systematic review was conducted by Kwan et al.  regarding  CPs  for
stroke patients6,7. They included both randomized and non-randomized studies
and found no evidence that CPs provided any significant additional benefit over
standard medical care in terms of major clinical outcomes (death or discharge
destination). Moreover, they concluded that stroke patients in CP groups were
more dependent on discharge, while the effect on LOS and hospitalization costs
remained unclear.
Despite these uncertainties, CPs have been widely used in many institutions
throughout the United States, the United Kingdom and some parts of Europe for
patients undergoing various treatments, surgeries or diagnostic procedures.
According to the results of the majority of publications in which clinical
pathways  were  compared  with  standard  care,  there  is  an  overall  tendency  to
come to the conclusion that CPs are effective in reducing LOS, costs,
complication rates and readmissions. On the other hand, CPs may positively
affect patients’ health-related functioning, quality of life or patient satisfaction.
However, some critical studies1,4,5,8 have introduced serious doubts about the
amount of the evidence and this criticism stimulated us to undertake this study.
The purpose of this study was to appraise the methodological qualities of clinical
pathway (CP) evaluation studies in order to evaluate the validity of the evidence
for  the  efficacy  CPs  and  to  suggest  improvements  in  future  study  design.
Methodological quality was defined through a set of parameters related to the
design and conduct of the study that determines the internal and external
validity of the study9–12.
2.2 Methods
Two search strategies were employed to find published studies on the efficacy of
CPs. The first strategy involved computerized database searches using Medline,
CINAHL,  Embase,  Psychinfo  and  Picarta  from  1995  till  2005.  Studies  were
identified by a broad range of keywords: clinical pathways, critical pathway,
clinical paths and integrated care pathway, effect, adults, paediatric diseases,
patient satisfaction, length of stay, complications, readmission, quality of care,
quality of life, costs, longitudinal studies, experimental studies, randomized
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controlled studies, cohort studies, double-blind methods, systematic review,
evaluation and comparative studies.
The second strategy concerned a snowball sampling method using the databases
of ISI Web of KnowledgeSM. We identified studies that were cited retrospectively
in  a  publication  on  the  effectiveness  of  CPs,  as  well  as  studies  that  cited  the
selected papers in the years following their publication.
2.2.1 Inclusion and exclusion of publications
Information from abstracts and titles of the papers that were detected using
both search strategies was used to include or exclude manuscripts. Papers were
excluded if they were:
• Manuscripts  that  addressed  the  noun  ‘pathway’,  but  were  not  related  to
studies   investigating  the  efficacy  of  a  CPs  in  terms  of  specified  guidelines  or
outlines for care that describe patient-treatment goals and define a sequence
and timing of interventions to meet those goals efficiently;
• Manuscripts concerning our definition of a CPs which did not provide
empirical quantitative results, such as letters to the editor, brief reports, case
studies, qualitative designs, opinions of experts, etc..
After exclusion of inappropriate manuscripts, two of the investigators (NEB and
BM) independently assessed the remaining publications in full text against two
criteria:
1. The study evaluated the efficacy of a CPs by means of quantitative methods
(e.g. a meta-analysis or systematic review).
2. The design of the effect study included a CPs group and a control group.
Papers were included if one or both investigators unequivocally considered the
publication as appropriate for analysis. Differences were resolved through
discussion with reference to a third reviewer (JPvD), if necessary.
Methodological appraisal included papers that satisfied both criteria.
2.2.2 Assessment of methodological quality
Two reviewers (NEB and BM) independently assessed the methodological
quality of the selected papers and recorded their findings with an evaluation tool
or scoring system comprising of a set of items for quality assessment from the
Cochrane Library and from other publications on quality assessment of studies
9–11,13. The quality score was based on eight items that evaluated the following
methodological characteristics of individual studies as presented in Table 1.
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The appraisal of the overall methodological quality was based on a weighted
score in which the similarity of groups at baseline, randomization and adequate
statistical methods were assigned three points; the use of power analysis and
control of confounders were assigned two points; and assessment by a medical
ethics committee, unbiased outcome measure and eligibility criteria were
assigned one point. We calculated overall quality scores for each study by
summing up the score-weighted ‘yes’ scores.
We  established  the  cut-off  point  between  ‘high’  and  ‘low’  quality  studies  by
following the method developed by Verhagen et al.12. They set the cut-off point at
50% of the maximum achievable score of 16 points, meaning high-quality studies
scored  ?8.0  and  low-quality  studies  scored  ?7.0  points.  In  addition  to  this
dichotomous scale, we arranged the quality scale scores into the following
ordinal categories: invalid studies (scores 0–3), weak to medium quality (scores
4–7), good quality (scores 8–11) and high quality (scores 12–16).
2.3 Analysis
Analyses were performed using SPSS version 12.0.1 (SPSS Inc., Chicago, IL,
USA) and for  all  tests  P < 0.05 was considered significant.  We calculated 95%
confidence intervals for the differences in proportions 14. Chi-square and
Fisher’s exact tests were used for associations between categorical variables.
Apart from the methodological parameters in Table 1., outcomes such as
decrease in LOS, costs, readmission and complications and their statistical
significance were observed.
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2.4 Results
Of the 556 publications that were analysed, 310 papers (55.7%) were not related
to our definition of a CPs at all as they addressed either metabolic, molecular or
genetic pathways, letters to the editor and editorials or investigated the effect of
a pharmacological therapy, or aspects of surgical techniques. Of the remaining
sample of 246 publications, 131 manuscripts were excluded because they either
did not meet the inclusion criterion regarding required study design (74 papers
contained no evaluation study, 52 papers addressed the definition or phases of
development of CPs and five were not in English). A total of 115 studies out of
556 investigated the efficacy of CPs according to our definition of CPs and these
were used for the assessment of methodological quality (see Figure 1.).
Figure 1. Flowchart describing study selection and excluded studies
2.4.1 Disease treatments
In the period between 1995 and 2005, 246 publications addressed relevant
aspects  of  CPs  in  terms  of  our  definition.  In  Table  2.,  these  publications  are
shown sorted by disease or intervention category. The most often studied
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category was in the field of cardiovascular surgery and diseases in both the
gross sample and study sample (21.5% and 17.4%, respectively). Twenty
publications evaluating cardiovascular clinical pathways were included in the
study sample15–34. The relative number (%) of publications included in the study
sample varied between 5% and 16% in the following domains: (1) respiratory
diseases, therapy and thoracic surgery28,35–51; (2) gastrointestinal surgery,
endoscopic surgery and diseases52–70;  (3)  orthopedic  surgery  and  multiple
trauma71–83; (4) oncological diseases and surgery84–92; (5) neurological trauma,
disorders, diseases and pain management93–100; (6) vascular surgery15,19,101–105;
and (7) gynaecological diseases, surgery and maternity care106–111.
Categories of diseases or treatment, which represent less than 5% of the study
sample, comprised studies on urological diseases, surgery and procedure112–116;
psychological disturbances and mental health117,118; metabolic diseases119;
paediatric conditions120–122; burn and skin reconstructive surgery123,124; and head
and neck surgery125,126.
We tested whether selection bias affected the sample of manuscripts used for
methodological analysis with 95% confidence intervals for differences in
proportions. The differences between the proportion of papers addressing the
effects of CPs on job satisfaction and papers not in English showed under-
representation in the final sample (used in the current study) as compared with
the total sample of CPs -related publications. The study sample of papers shows
a similar distribution across diseases as compared with the gross sample,
indicating a good representation of the population of studies published between
1995 and 2005.
2.4.2 Designs
Of the 246 papers, 131 were excluded because of the fact that they were
descriptive studies or review articles and only the remaining 115 publications
were included based on the criteria of study design. Ten randomized controlled
studies  were found and the majority  (n=105)  were comprised of  studies  with a
retrospective comparative research design or were cross-sectional retrospective
studies that compared the differences in patient outcome during a period before
and after implementation of CPs. The following retrospective designs were used:
1. A  majority  of  these  studies  (n=96)  used  a  historical  control  group  and  were
conducted at the same hospital (before–after design).
2. Three studies were conducted with a historical control group from a different
hospital and at different time periods.
3. Six studies were conducted using concurrent control and experimental groups
either  in  the  same  hospital,  though  using  separate  wards,  or  in  different
hospitals.
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Ten studies, labeled as randomized controlled studies, comprised studies that
randomly selected hospitals45,127 where  a  pathway  was  implemented  or  that
assigned patients randomly to either pathway care or standard care.
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These randomized controlled studies followed up patients after discharge for
outcomes like quality of life, pain, readmission, mortality and complications.
One paper assessed patients at baseline, 3, 6 and 12 months117, and another
measured patients 1 week after assignment to CP or conventional care and then
at 4, 12 and up to 26 weeks96–98. The remaining papers followed up patients after
discharge from the health care facility at a time ranging from 10 days up to 12
weeks42,45,56,72,127,128.
2.4.3 Randomization and matching
We detected 12 retrospective studies (10.4%) that controlled for confounding
through matching, of which three studies used a random sample from a CP
group which was matched with controls from the pre-pathway period25,30,
48,50,58,79,81,107,110,111,122,129. Furthermore, 10 randomized controlled studies were
found, of which two studies randomly assigned hospitals either to implement a
CP or to remain on standard care45,127. Eight studies randomly assigned patients
to either a CP or standard care42,56,72,96–98,117,128.
2.4.4 Power analysis
The  question  of  what  sample  size  to  use  constitutes  a  crucial  part  of  any
research proposal. However, only 16.5% (n=19) of the studies conducted a power
analysis to determine in advance the required number of observations which
would be sufficient to provide the required precision of results. Among the 115
studies, 25% of the samples were very small (n<50), 25% ranged from 51 to 100
patients, 25% ranged from 100 to 200 patients and 25% had samples greater
than  200  patients  in  either  the  CP  or  the  control  group.  No  statistically
significant association was found between sample size (n<100 vs. n>100) and
performance for a statistical power analysis (Chi-square, P=0.56).
2.4.5 Control for confounding
In less than half of the studies (42.1%), the authors did pay attention to the
problem of controlling for potential confounders and either applied direct control
with randomization or matching (17.5%), and/or used a control for confounders
(e.g. co-morbidity, age and gender) in regression models (24.6%). The other
(57.9%) did not take the potential risk of confounders into account at all.
Selection bias may occur when inclusion and exclusion criteria are obscure. In
57 of the studies that were appraised (49.6%), misleading conclusions were
prone to arise based on the fact that patients in ‘experimental’ groups differed
from the control group patients regarding characteristics such as differences in
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age, gender, disease severity or co-morbidity. The other half of the studies
meticulously described criteria for inclusion and exclusion.
2.4.6 Accuracy and validity of outcome measures
Length of stay was evaluated in 108 publications (93.3%). However, more than a
quarter (28.1%) of these studies gave no accurate or meticulous description of its
operationalization or  a  clear  description of  the way it  was assessed.  Costs  and
hospital charges were assessed in 73 papers (63.5%), among which 62 (53.9%)
stated a clear description of the charges and costs calculated.
• Readmission rates were calculated in 53 papers (46.1%), of which 50 (43.5%)
precisely defined readmission within a time frame.
• Complications were evaluated in 70 papers (60.9%), of which 64 (55.6%)
defined and clearly stated the complications.
• Quality of life was  assessed  in  10  (8.7%)  of  the  studies  with  a  validated
measure. Functional health-related functioning was measured in six (5.2%)
studies, and both quality of life and health status were measured in two papers.
Three studies (2.6%) assessed psychological distress (anxiety and depression).
However, only two studies used a validated measure: the Hospital and Anxiety
and Depression Scale48,98.
• Patient satisfaction was assessed in 15 studies (13.0%), but was measured
with a multi-item tool in 13 studies (11.3%). Work satisfaction was evaluated in
four (3.5%) of the studies, and three studies presented an accurate description of
this construct. Clinical quality-of-care indicators were evaluated in 57 (49.6%)
papers and were accurately defined in all cases.
2.4.7 Appropriateness of statistical methods
More than half (59.1%) of the studies adopted parametric statistical tests
without question, but the rest (40.9%) tested variables over normal distribution
and, depending on the outcome, used non-parametric tests. Reduction of LOS,
costs, readmission rates and number of complications belong to the most
relevant targets for implementing CPs.
However, decreases in LOS, costs, readmission rates and number of
complications were not statistically tested in 12.3%, 28.8%, 20.8% and 27.1% of
the studies, respectively16–19,22,23,25–28,32,33,36–38,42,44–47,49,53,61,75,85,88,91,92,99–103,105,110,
113,120.  There  were  studies  that  used  a  statistical  test  to  decide  whether  a
difference  between  a  CP  group  and  a  control  group  was  due  to  sample
fluctuation, but they also reported other differences without this test. For the
main outcome parameters, LOS, readmission rates, costs and number of
complications (65%) of the studies tested for each outcome (23%) did not test for
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all differences between CPs and controls, while (12%) did not apply any test at
all.
2.4.8 Quality of studies related to statistically significant outcomes
We found 92 publications that reported a decrease in LOS and 60 that reported
a decrease in costs. All the good-quality studies reported a statistically
significant result in both LOS and costs. However, among the low-quality
studies  (84%)  of  the  papers  reported  a  reduction  in  LOS that  was  statistically
significant, and only 68% of the publications reported a decrease in costs which
was statistically significant (Fisher’s exact test, P=0.02 and P=0.03,
respectively). There was no association between quality of the studies and the
statistical significance of the reduction in complications and in readmission
rates (see Table 3).
2.4.9 Overall quality related to other study characteristics
According to the dichotomous threshold of Verhagen et al.12, one-third of the
papers (33%) analysed were classified as high-quality papers, while 67% were
classified as studies of low quality. However, the ordinal quality scale showed
that  35.7% of  the  studies  reflected  low  quality,  that  is,  invalid  studies  (31.1%)
were appraised as weak- to medium-quality studies, and 24.3% as good-quality
studies. Finally, 8.7% of the sample reflected very good quality.
No statistically significant associations were found between the quality of the
studies and the sample size (Mann–Whitney U-test/Wilcoxon W-test, Z=?0.48,
P=0.63). Across the diseases shown in Table 1., the differences between
proportions of low- or high-quality studies were not statistically significant.
Furthermore, the quality of the studies was not associated with treatment in
terms of surgery versus non-surgery (Fisher’s exact test, P=0.31).
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Data extracted from hospital records were used in 81% of the studies and 19%
used self-reported questionnaires or interviews in combination with data from
the hospital records.
Both dichotomous and ordinal categorization confirmed that studies which
qualified as ‘good quality’ were more likely to use patient record information in
combination with self-report questionnaires or interviews (Fisher’s exact test,
P=0.01). Because of the fact that the majority of studies (91.3%) used electronic
databases, the question of whether dropouts were analysed appropriately did
not  play  a  significant  role  in  our  analysis.  A  significant  association  was  found
between the quality of the study and its design. Only 27% of the studies with a
retrospective design were classified as of good quality (Fisher’s exact test,
P=0.0001), whereas all randomized controlled studies were of high quality.
2.5 discussion
The majority of the publications on CP we analysed were classified as studies of
low quality (67%), which raise questions about the validity of the evidence for
the implementation of CP in the last decade.
The methodology of studies assessing the efficacy of CPs has been criticized in
regard to their research designs, poor reporting of the methodology and under-
powered sample sizes1,3,5–8. Therefore, we performed an appraisal and analysis of
the methodological qualities of a large number of CP evaluation studies in order
to investigate the validity of their outcomes.
In relation to the internal and external validity of the studies in the sample, our
analysis revealed several factors that influenced the quality of CP evaluation.
Most studies in our sample concerned non-randomly selected small patient
populations without a power analysis19,23,25,36,52,54,56,58,59,61,76,81,86–88,91,99,107,111,118,122,
123,126,128.
Furthermore, in many studies selection bias has occurred. Patients selected for
a  CP  were  likely  to  differ  from  patients  managed  with  standard  care  using
characteristics known to be associated with LOS and hospital delay, and
consequently  included costs  such as  age and co-morbidity.  In half  of  the study
sample (49.6%), the inclusion and exclusion criteria of patients were obscure and
difficult to relate to the population’s characteristics. According to our findings,
only 12 retrospective studies (10.4%) controlled for selection bias by matching,
out  of  which  three  studies  matched  a  random  sample  from  a  CP  group  with
controls from the pre-pathway period group 25,30,48,50,58,79,81,107,110,111,122,129.
In regard to the outcomes measured, our analysis also revealed that most
studies  focused  on  cost  issues  and  reductions  in  LOS.  However,  clinically
relevant outcomes such as mortality, discharge disposition, quality of care as
seen through the eyes of the patient, psychological distress (anxiety), care
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dependency and use of health services after discharge were largely ignored. A
few studies focused on outcome in terms of: (1) destination of
discharge21,24,69,72,78,98,101,104,122; (2) delay44,109; (3) patient education32,124; (4) quality
of care22,74; and (5) psychological distress48,98.
In relation to the use of appropriate statistical tests, more than half (59.1%) of
the studies adopted parametric statistical tests without question, but 40.9%
tested variables on normal distribution and, depending on the outcome, used
non-parametric tests. Before–after differences in frequently measured outcomes
such as LOS, costs, readmission and complications were statistically tested in
few of the studies. Other studies used statistical tests to decide whether
differences between groups were related to sample fluctuations, while also
reporting other differences without statistical tests. After reviewing all papers
included, it was clear that there was an inevitable risk of misrepresentation of
the true costs.
Reduced  LOS  in  the  hospital  may  lead  to  admission  to  another  health  care
facility, for example, a rehabilitation unit or extended care facility. Although
costs related to these services are not considered as a part of hospital charges,
they still add to direct health care costs and may also lead to out-of-pocket
expenses for the patient. Furthermore, studies that report reduction in both
LOS and costs do not take into consideration that both are interrelated, which
leads to contamination in statistical analysis.
Moreover, from a methodological point of view both the investigators (who
assessed the outcomes) and the health care providers should have been blinded
to  the  use  of  a  CP  since  this  might  have  biased  their  observations  and
assignment procedure.
In the light of these findings, it can be concluded that readers must be extremely
cautious when interpreting the results of CP evaluation studies because of the
confounding factors and the sources of contamination affecting the internal and
external validity of most of the published studies.
2.6 Recommendations for future research
After reviewing a large number of CP evaluation studies and having stated our
conclusions, we recommend that:
1. More (randomized) controlled studies should be conducted, in which patients
are randomly assigned to the condition of either a pathway or standard should
be conducted. However, such randomized controlled studies in the same hospital
invite  contamination,  because  many  of  the  same  doctors,  as  well  as  care  staff,
are involved in treating the same population of patients. To avoid such
Hawthorne effects, we suggest establishing multi-centre trials with
randomization after pre-stratification of confounding factors (e.g. gender, co-
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morbidity) with a clearly defined method of randomization, concealment of
allocation or blinding with the appropriate balancing method 130.
2. Standardization of the total direct costs is specified by clearly defined cost
components and a standardized operational definition of LOS. LOS should not
be confined to the hospital setting, but should be extended to include whether
patients are discharged home or to an extended health care facility, and should
include whether this is a permanent or temporary arrangement. An accurate
calculation in this case will reflect the true effect of CPs on LOS and subsequent
related costs.
3. More attention should be paid to measuring relevant patient outcomes such
as quality of life, hospital anxiety, patient expectations and satisfaction with
standardized validated tools, which reflect the true effect with use of
appropriate statistical methods.
Until the results of good-quality research are more widely available, CPs should
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